Humira Reduces Early Ulcerative Colitis Features, Trial Analysis Shows
News
AbbVie‘s Humira (adalimumab) reduces early tissue inflammation, rectal bleeding, and stool frequency in patients with ulcerative colitis, according to a post-hoc analysis of two Phase 3 trials. Findings were published in ... Read more